Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer

Cisplatin is a widely used platinum‐based chemotherapy agent. Its common adverse effects are neuropathy, nephrotoxicity, electrolyte abnormality, and rarely causing thrombotic vascular toxicity. We present a patient known to have small‐cell lung cancer who developed ischemic cerebrovascular accident...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashid, Farah, Omar, Nabil E., Aaekl, Hassan, Al Homsi, Ussama, Shablak, Alaaeldin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585048/
https://www.ncbi.nlm.nih.gov/pubmed/36285031
http://dx.doi.org/10.1002/ccr3.6469
_version_ 1784813412199432192
author Rashid, Farah
Omar, Nabil E.
Aaekl, Hassan
Al Homsi, Ussama
Shablak, Alaaeldin
author_facet Rashid, Farah
Omar, Nabil E.
Aaekl, Hassan
Al Homsi, Ussama
Shablak, Alaaeldin
author_sort Rashid, Farah
collection PubMed
description Cisplatin is a widely used platinum‐based chemotherapy agent. Its common adverse effects are neuropathy, nephrotoxicity, electrolyte abnormality, and rarely causing thrombotic vascular toxicity. We present a patient known to have small‐cell lung cancer who developed ischemic cerebrovascular accident (CVA) after receiving chemotherapy regimen including cisplatin.
format Online
Article
Text
id pubmed-9585048
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95850482022-10-24 Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer Rashid, Farah Omar, Nabil E. Aaekl, Hassan Al Homsi, Ussama Shablak, Alaaeldin Clin Case Rep Case Report Cisplatin is a widely used platinum‐based chemotherapy agent. Its common adverse effects are neuropathy, nephrotoxicity, electrolyte abnormality, and rarely causing thrombotic vascular toxicity. We present a patient known to have small‐cell lung cancer who developed ischemic cerebrovascular accident (CVA) after receiving chemotherapy regimen including cisplatin. John Wiley and Sons Inc. 2022-10-20 /pmc/articles/PMC9585048/ /pubmed/36285031 http://dx.doi.org/10.1002/ccr3.6469 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Rashid, Farah
Omar, Nabil E.
Aaekl, Hassan
Al Homsi, Ussama
Shablak, Alaaeldin
Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer
title Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer
title_full Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer
title_fullStr Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer
title_full_unstemmed Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer
title_short Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer
title_sort successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585048/
https://www.ncbi.nlm.nih.gov/pubmed/36285031
http://dx.doi.org/10.1002/ccr3.6469
work_keys_str_mv AT rashidfarah successfulrechallengewithcisplatinfollowingcisplatininducedischemiccerebrovascularaccidentinapatientwithsmallcelllungcancer
AT omarnabile successfulrechallengewithcisplatinfollowingcisplatininducedischemiccerebrovascularaccidentinapatientwithsmallcelllungcancer
AT aaeklhassan successfulrechallengewithcisplatinfollowingcisplatininducedischemiccerebrovascularaccidentinapatientwithsmallcelllungcancer
AT alhomsiussama successfulrechallengewithcisplatinfollowingcisplatininducedischemiccerebrovascularaccidentinapatientwithsmallcelllungcancer
AT shablakalaaeldin successfulrechallengewithcisplatinfollowingcisplatininducedischemiccerebrovascularaccidentinapatientwithsmallcelllungcancer

Ejemplares similares